Navigation Links
Anthera's A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
Date:12/18/2007

cell disease, acute chest syndrome. Acute chest syndrome is a form of acute lung injury and is the leading cause of death in sickle cell disease patients. It commonly follows admission to the hospital for other reasons, especially an episode of bone pain (a prominent feature of sickle cell disease). Recent academic clinical studies have demonstrated that serum secretory phospholipase A2 (sPLA2) levels rise in advance of acute chest syndrome, and therefore help identify patients at-risk. This creates a unique opportunity for early intervention for a serious inflammatory lung disease with a potent inhibitor of sPLA2 such as A-001. Worldwide, nearly 200,000 suffer from some form of sickle cell disease. It accounts for an estimated 60,000 hospitalizations per year and significantly reduces life expectancy.

"Current treatment options are limited for even the common complications of sickle cell disease. As such, discovery of sPLA2 as a potential therapeutic target for patients at risk for acute chest syndrome has opened new prevention and treatment opportunities," says Clark Brown, M.D., Ph.D., IMPACTS investigator at Emory University, and a physician at the Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta. "The IMPACTS study represents a promising step forward in the care of patients with sickle cell disease."

Further information about this clinical trial, sickle cell disease, and acute chest syndrome can be found at http://www.IMPACTStrial.com

About Orphan Drug Designation

Orphan Drug designation grants special status to promising new therapies that treat conditions affecting fewer than 200,000 patients in the United States and entitles seven years of market exclusivity. Additionally, the sponsor of the product is offered incentives which include eligibility for research grants, certain tax benefits, protocol assistance and possible exemptions or reduc
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
3. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
4. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
5. GlaxoSmithKline Receives New HHS Order for H5N1 Bulk Antigen. First North American Clinical Trials with GSKs Candidate Pre-pandemic Flu Vaccine to Start.
6. CryoCor Receives FDA Approval for Right Atrial Flutter
7. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
8. Dimericine(R) Receives FDA Fast Track Designation for Treatment Of Photosensitivity in XP Patients
9. Poniard Pharmaceuticals Receives FDA Fast Track Designation for Picoplatin for Treatment of Small Cell Lung Cancer
10. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
11. The Female Health Company Receives USAID DELIVER PROJECT Order for 5 Million Units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 iHealth Lab Inc., ... wireless personal healthcare products and a powerful integrated ... the release of two new fitness products to ... and scales: the Wireless Pulse Oximeter and Wireless ... http://photos.prnewswire.com/prnh/20130521/SF17618 ) iHealth Lab is ...
(Date:5/21/2013)... , May 21, 2013  Lehigh Valley Health Network ... TM devices, adding to its existing arsenal of ... taking up residence within the network, LVHN is now ... to proactively combat superbugs and provide the best possible ... Room Ultraviolet Disinfector, TRU-D – the signature product of ...
(Date:5/21/2013)... , May 21, 2013  Healthcare organizations expanding ... Russia , India ... realizing there are no shortcuts.  This is proving particularly ... United States.  Companies must change the dialogue around BRIC, ... to local needs, and building regional partnerships to build ...
Breaking Medicine Technology:iHealth Lab adds new products and partners to mobile personal healthcare offering 2iHealth Lab adds new products and partners to mobile personal healthcare offering 3Lehigh Valley Expands Fleet of Superbug-Slaying Robots 2Lehigh Valley Expands Fleet of Superbug-Slaying Robots 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 2Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 4
... 8, 2012  Marshall Edwards, Inc. (Nasdaq: MSHL ... of novel therapeutics targeting cancer metabolism, announced that its ... $4 million of Units, subject to availability, in Marshall ... of Novogen stockholders in Sydney on Monday. ...
... MONICA, Calif., May 8, 2012 Reprints Desk, Inc., ... and first sale of its new mobile-web application ... iPads, mobile devices, product websites, and portals for ... Article Viewer for use by companies in Pharmaceuticals, Biotechnology, ...
Cached Medicine Technology:Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering 2Marshall Edwards Receives $4 Million Subscription From Novogen In Rights Offering 3Medical Reprints Deployment on iPads and Websites Made Easier with New ePrints Mobile-Web App from Reprints Desk 2Medical Reprints Deployment on iPads and Websites Made Easier with New ePrints Mobile-Web App from Reprints Desk 3
(Date:5/21/2013)... By Amy Norton HealthDay Reporter , , TUESDAY, ... alterations in two genes may be at increased risk ... study suggests. The researchers hope they can use ... help spot pregnant women who are vulnerable to postpartum ... Their study, reported in the May 21 issue ...
(Date:5/21/2013)... 21, 2013 The Special Olympics Missouri State ... from across the state to Columbia. This state-level event takes ... of Missouri and Columbia College, and at Hickman High School ... Games officially kick off at 7:30 p.m. Friday, May 30 ... Go Wild! theme, the Parade of Athletes, the culmination of ...
(Date:5/21/2013)... Not all treatments are effective when it ... Disorder (BPD) and addiction. Dialectical Behavior Therapy (DBT) is ... the treatment of both BPD and substance abuse. , ... director of Clearview Women’s Center for Borderline Personality ... of the West Coast Symposium on Addictive Disorders (WCSAD), ...
(Date:5/21/2013)... May 21, 2013 Children with autism showed significant ... home using everyday items such as scents, spoons and ... that a treatment known as environmental enrichment led to ... 3 and 12. Results appear online in Behavioral ... Leon randomly assigned 28 boys to one of two ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 STAR ... center for children with sensory challenges and the ... in research, education and advocacy of Sensory Processing Disorder ... SPD: Strategies to Improve Quality of Life, a two-hour ... Temple University, Pennsylvania. , Learn a method that ...
Breaking Medicine News(10 mins):Health News:Genes May Boost Woman's Risk of Postpartum Depression 2Health News:Genes May Boost Woman's Risk of Postpartum Depression 3Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 2Health News:Special Olympics Missouri Athletes Ready to Show Off Skills in Columbia 3Health News:Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD 2Health News:Clearview Treatment Programs Clinical Director to Present on DBT and Substance Abuse at WCSAD 3Health News:Enrichment therapy effective among children with autism, UCI study finds 2Health News:STAR Center and SPD Foundation Present a Lecture on Teens and Adults with Sensory Processing Disorder 2Health News:STAR Center and SPD Foundation Present a Lecture on Teens and Adults with Sensory Processing Disorder 3
... to various health complications in newborns, says a study//. ... foods like nuts, vegetable oil and broccoli. Earlier research ... C, could help protect against miscarriage and pre-eclampsia. ... study at St. Thomas' Hospital in London, warned that ...
... who had heart attack, and stopped taking antiplatelet drugs within ... times more risk of death than others. ,"An ... their antiplatelet medication within the first 30 days of receiving ... drugs at the time of hospital discharge and recommendations are ...
... from Florida have stated on Tuesday that a short course ... with rotavirus, //which kills half a million youngsters in mainly ... by the privately owned U.S. Company, Romark Laboratories under the ... problem in just over 30 hours in young children with ...
... it was found that hydrogenated fat or processed fat resulted ... biscuits to cut manufacturing costs of foods and increase their ... and ready meals. People put on weight especially in the ... by heating natural fats to 250C and then bubbling hydrogen ...
... glucose metabolism, which occurs when the body has difficulty ... among patients //with chronic nerve dysfunction of unknown cause ... risk factor for the condition, according to a study ... 2006 print issue of Archives of Neurology, one of ...
... of Assam Tarun Gogoi had today undergone treatment at the ... ,Sources close to him explained that Gogoi, who ... Europe and Canada, was taken to AIIMS as he had ... Gogoi at the AIIMS said that he was suffering from ...
Cached Medicine News:Health News:Risk Of Death Increases With Sudden Withdrawal Of Medications 2Health News:Risk Of Death Increases With Sudden Withdrawal Of Medications 3Health News:Hydrogenated Fat Pts Weight around the Abdomen 2Health News:Abnormal Glucose Metabolism May Contribute to Chronic Nerve Disorder 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: